EPITOME-2: An open-label study assessing the transition to a new formulation of intravenous epoprostenol in patients with pulmonary arterial hypertension

Olivier Sitbon, Marion Delcroix, Emmanuel Bergot, Anco B. Boonstra, John Granton, David Langleben, Pilar Escribano Subías, Nazzareno Galiè, Thomas Pfister, Jean-Christophe Lemarié, Gérald Simonneau
  • American Heart Journal, February 2014, Elsevier
  • DOI: 10.1016/j.ahj.2013.08.007

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication


The following have contributed to this page: Olivier Sitbon and Professor Olivier SITBON